SHALABY, SARAH
 Distribuzione geografica
Continente #
NA - Nord America 1416
EU - Europa 167
AS - Asia 82
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1668
Nazione #
US - Stati Uniti d'America 1416
CN - Cina 77
IT - Italia 77
SE - Svezia 26
DE - Germania 17
FI - Finlandia 11
FR - Francia 6
IE - Irlanda 6
NL - Olanda 6
GB - Regno Unito 4
RO - Romania 4
PL - Polonia 3
UA - Ucraina 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ES - Italia 2
IN - India 2
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
IR - Iran 1
RS - Serbia 1
TR - Turchia 1
Totale 1668
Città #
Fairfield 301
Chandler 161
Woodbridge 140
Seattle 122
Cambridge 109
Ashburn 100
Houston 99
Wilmington 87
Ann Arbor 77
San Diego 54
Medford 32
Princeton 32
Padova 26
Des Moines 24
Roxbury 19
Beijing 16
Boardman 13
Helsinki 11
Nanjing 11
Dearborn 10
Hefei 8
Guangzhou 7
Dublin 6
Jinan 6
Milan 5
Nanchang 4
Trieste 4
Bologna 3
Kunming 3
Shenyang 3
Forlì 2
Fuzhou 2
Hangzhou 2
Hebei 2
Kharkiv 2
London 2
Ningbo 2
Norwalk 2
Phoenix 2
Piacenza 2
Redwood City 2
Tianjin 2
Weimar 2
Adliswil 1
Alexandria 1
Amsterdam 1
Andover 1
Biassono 1
Campolongo 1
Changsha 1
Chaoyang 1
Clearwater 1
Foggia 1
Granada 1
Guiyang 1
Hunedoara 1
Huzhou 1
Istanbul 1
Jiaxing 1
Legnago 1
Modena 1
Málaga 1
Naples 1
Quzhou 1
Reghin 1
Rockville 1
Saint Louis 1
Taizhou 1
Tione Di Trento 1
Udine 1
Valbonne 1
Verona 1
Villafranca 1
Warsaw 1
Totale 1550
Nome #
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 140
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 109
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 97
Management of bacterial infection in the liver transplant candidate 89
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 88
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 86
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014 82
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 79
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 78
Survival after the diagnosis of de novo malignancy in liver transplant recipients 74
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 66
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 66
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 58
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 58
Local prothrombotic state in portal venous system in cirrhosis 57
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 43
Long-term care of transplant recipients: de novo neoplasms after liver transplantation 39
Management of portal hypertension severe complications 34
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 34
Reply 33
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 29
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 29
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 28
De novo and recurrent malignancy 27
Drug induced liver injury: from pathogenesis to liver transplantation 27
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 27
An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know 24
Malnourished cirrhotic patient: what should we do? 23
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 21
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 17
New indications for liver transplantation 15
Recent advances in the management of acute variceal hemorrhage 15
Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis" 9
Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients 6
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 4
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 3
Vascular liver diseases: A sex-oriented analysis of the literature 2
Sex disparity and drug-induced liver injury 1
Totale 1717
Categoria #
all - tutte 3970
article - articoli 3511
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201818 0000 00 010 1070
2018/2019177 0264 50 33 2296558
2019/2020441 4035647 4536 6348 53341816
2020/2021319 14202523 621 1127 36452962
2021/2022498 23245427 2167 4137 242943108
2022/2023261 6132737 6642 115 0000
Totale 1717